These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase. Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004 [TBL] [Abstract][Full Text] [Related]
8. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins]. Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582 [TBL] [Abstract][Full Text] [Related]
9. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates. Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412 [TBL] [Abstract][Full Text] [Related]
10. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009]. Kwiecińska-Piróg J; Bogiel T; Gospodarek E Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis. Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101 [No Abstract] [Full Text] [Related]
12. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. D'Andrea MM; Nucleo E; Luzzaro F; Giani T; Migliavacca R; Vailati F; Kroumova V; Pagani L; Rossolini GM Antimicrob Agents Chemother; 2006 Feb; 50(2):618-24. PubMed ID: 16436718 [TBL] [Abstract][Full Text] [Related]
13. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935 [TBL] [Abstract][Full Text] [Related]
15. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. Palasubramaniam S; Muniandy S; Navaratnam P J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644 [TBL] [Abstract][Full Text] [Related]
16. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY; Ng SY; Teo L; Koh Y; Teok CH J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of the ambler class C beta-lactamase of Yersinia ruckeri. Mammeri H; Poirel L; Nazik H; Nordmann P FEMS Microbiol Lett; 2006 Apr; 257(1):57-62. PubMed ID: 16553832 [TBL] [Abstract][Full Text] [Related]
18. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415 [TBL] [Abstract][Full Text] [Related]